Biden WH Has Yet To Decide Whether To Restart FDA Regulation Of LDTs

By Kelly Lienhard / February 9, 2021 at 5:51 PM

The Biden White House has yet to decide whether to restore FDA’s regulation of laboratory-developed tests as it faces pressure from current and former FDA officials to revoke a controversial move by the Trump HHS to ax FDA’s oversight of the products.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.